Announcement • Jul 07
The Hempshire Group, Inc., Annual General Meeting, Jul 24, 2025 The Hempshire Group, Inc., Annual General Meeting, Jul 24, 2025. Announcement • Nov 01
The Hempshire Group to Transfer Listing from TSX Venture Tier 2 to NEX, Effective November 4, 2024 In accordance with TSX Venture Policy 2.5, The Hempshire Group, Inc. has not maintained the requirements for a TSX Venture Tier 2 company. Therefore, effective at the opening on November 4, 2024, the Company's listing will transfer to NEX, the Company's Tier classification will change from Tier 2 to NEX, and the Filing and Service Office will change from Calgary to NEX. As of November 4, 2024, the Company is subject to restrictions on share issuances and certain types of payments as set out in the NEX policies. The trading symbol for the Company will change from HMPG to HMPG.H. There is no change in the Company's name, no change in its CUSIP number and no consolidation of capital. The symbol extension differentiates NEX symbols from Tier 1 or Tier 2 symbols within the TSX Venture market. Further to the TSX Venture bulletin dated July 15, 2024, trading in the shares of the Company will remain suspended. New Risk • Jul 07
New major risk - Shareholder dilution The company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 77% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Shares are highly illiquid. Negative equity (-US$176k). Shareholders have been substantially diluted in the past year (77% increase in shares outstanding). Revenue is less than US$1m (US$197k revenue). Market cap is less than US$10m (CA$2.11m market cap, or US$1.55m). Minor Risk Latest financial reports are more than 6 months old (reported September 2023 fiscal period end). Announcement • Jun 27
The Hempshire Group, Inc., Annual General Meeting, Sep 17, 2024 The Hempshire Group, Inc., Annual General Meeting, Sep 17, 2024. New Risk • Jun 17
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended September 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-US$1.2m free cash flow). Shares are highly illiquid. Negative equity (-US$176k). Revenue is less than US$1m (US$197k revenue). Market cap is less than US$10m (CA$1.22m market cap, or US$888.4k). Minor Risks Latest financial reports are more than 6 months old (reported September 2023 fiscal period end). Shareholders have been diluted in the past year (2.2% increase in shares outstanding). Board Change • May 08
High number of new and inexperienced directors There are 4 new directors who have joined the board in the last 3 years. The company's board is composed of: 4 new directors. No experienced directors. No highly experienced directors. Independent Director Samuel Isaac is the most experienced director on the board, commencing their role in 2022. The company’s lack of experienced directors is considered a risk according to the Simply Wall St Risk Model. Reported Earnings • Dec 01
Third quarter 2023 earnings released: US$0.006 loss per share (vs US$0.014 loss in 3Q 2022) Third quarter 2023 results: US$0.006 loss per share (improved from US$0.014 loss in 3Q 2022). Revenue: US$49.2k (up 148% from 3Q 2022). Net loss: US$377.4k (loss narrowed 50% from 3Q 2022). Board Change • Nov 16
High number of new and inexperienced directors There are 4 new directors who have joined the board in the last 3 years. The company's board is composed of: 4 new directors. No experienced directors. No highly experienced directors. Independent Director Samuel Isaac is the most experienced director on the board, commencing their role in 2022. The company’s lack of experienced directors is considered a risk according to the Simply Wall St Risk Model. Announcement • Sep 13
The Hempshire Group, Inc. Announces Management Changes, Effective September 29, 2023 The Hempshire Group, Inc. announced the resignation of Chief Financial Officer ("CFO") William Hahn, effective September 29, 2023 who has accepted a new position in a different industry. The Company will appoint Paul Stacey to the role of Interim CFO effective September 29, 2023. Mr. Stacey is a seasoned CFO and brings with him extensive and relevant industry experience, and strong executive leadership in the areas of corporate finance, financial planning, strategy and operations. Mr. Stacey served as the Chief Financial Officer of Dr. Murphys – a well-respected cannabis extraction and distribution facility with its own brand in market. Prior to Dr. Murphys, Paul was variably the CFO or the COO of a number of businesses or start-ups through a partnership with private equity funds. As a partner or advisor to private equity firms Paul managed and improved cashflow, grew revenues and optimized assets and pricing for a number of private equity owned consumer packaged goods companies. Earlier in his career, Paul held leadership roles with Gund, Ricoh USA, Cendant and Nabisco. He started his career as an auditor with PriceWaterhouseCoopers. New Risk • Sep 07
New minor risk - Shareholder dilution The company's shareholders have been diluted in the past year. Increase in shares outstanding: 2.2% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-US$3.3m free cash flow). Share price has been highly volatile over the past 3 months (32% average weekly change). Revenue is less than US$1m (US$168k revenue). Market cap is less than US$10m (CA$4.47m market cap, or US$3.28m). Minor Risk Shareholders have been diluted in the past year (2.2% increase in shares outstanding). Reported Earnings • Sep 03
Second quarter 2023 earnings released: US$0.01 loss per share (vs US$0.075 loss in 2Q 2022) Second quarter 2023 results: US$0.01 loss per share (improved from US$0.075 loss in 2Q 2022). Revenue: US$56.2k (up 187% from 2Q 2022). Net loss: US$609.8k (loss narrowed 85% from 2Q 2022). Announcement • Jul 01
The Hempshire Group, Inc. Announces Board Changes The Hempshire Group, Inc. (formerly Hoist Capital Corp.) announced that Gail Hannon has advised the Board of Directors that she will resign from her role as a director effective June 30, 2023. The Board of Directors has appointed Jason Warnock as a director of Hempshire effective June 30, 2023. Mr. Warnock is an accomplished global sales leader and executive, bringing more than 20 years of experience driving revenue growth and international market strategy for high-profile, Fortune 500 brands. Mr. Warnock has spent the last 16 years in the cannabis, competitive advertising, communications, and emerging technology fields where his work focused on building companies and brands from the ground up, working on strategic mergers and acquisitions, international cannabis regulations and creating communication and advocacy campaigns. He is experienced in delivering consistent and sustainable business results for numerous consumer packaged goods companies, integrating regulatory and international cannabis supply chains and developing high-performance go-to-market sales teams. Announcement • Jun 13
The Hempshire Group, Inc., Annual General Meeting, Aug 22, 2023 The Hempshire Group, Inc., Annual General Meeting, Aug 22, 2023. Agenda: Annual General and Special Meeting. Reported Earnings • Jun 04
First quarter 2023 earnings released: US$0.01 loss per share (vs US$0.063 loss in 1Q 2022) First quarter 2023 results: US$0.01 loss per share (improved from US$0.063 loss in 1Q 2022). Revenue: US$65.8k (up 181% from 1Q 2022). Net loss: US$488.1k (loss narrowed 26% from 1Q 2022). Reported Earnings • Dec 01
Third quarter 2022 earnings released Third quarter 2022 results: US$0.014 loss per share. Net loss: US$756.8k (flat on 3Q 2021). Board Change • Nov 16
No independent directors Following the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 4 non-independent directors. CEO, President & Director Marty Marion was the last director to join the board, commencing their role in 2021. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model. Announcement • Sep 08
The Hempshire Group, Inc. Announces Receipt of Regulatory Approval to Import Its Products into the European Union The Hempshire Group, Inc. announced receipt of regulatory approval to import its products into the European Union (EU), and the designation of an exclusive European master distributor. Belgian Approval Hempshire announced it has received notice from the Federal Public Health Food Safety and Environment Service of Belgium, an EU member nation, that MOUNTAIN(R) Smokes have been found to conform with European Union Common Entry Gate (EU-CEG) regulations, including regulations governing tobacco and smokable products and the pertinent regulations setting maximum THC levels at under 0.2%. The notice allows MOUNTAIN(R) Smokes to be legally imported into, and commercially sold in, the country. Access to the European Union (EU) As per EU member state reciprocity for the inter-member commercialization of goods, the Belgian authorization allows Hempshire to pursue commercialization and sales across the EU -- provided it complies with individual member nations' specific 'local' regulations, such as packaging in the local language, and inclusion of any locally-required warning labels. Reported Earnings • Sep 02
Second quarter 2022 earnings released Second quarter 2022 results: US$0.075 loss per share. Net loss: US$4.05m (flat on 2Q 2021). Board Change • Aug 26
No independent directors Following the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 4 non-independent directors. CEO, President & Director Martin Marion was the last director to join the board, commencing their role in 2021. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model. 